Such killing requires effective priming of tumor antigen specific CD8+ T cells within the draining lymph nodes; differentiation into CTL; effective tumor infiltration and execution of the cytolytic effector function within the tumor microenvironment. The gene discussed is CD8A; the disease is neoplasm.